MedPath

Translational research regarding the effect of TS-1 on CECs from metastatic or relapsed breast cancer patients.

Not Applicable
Conditions
metastatic or relapsed breast cancer
Registration Number
JPRN-UMIN000002793
Lead Sponsor
Kyoto University Hospital, Breast Surgery Department
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
12
Inclusion Criteria

Not provided

Exclusion Criteria

1)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the changes of CECs or CEPs from the patients treated with TS-1.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath